Cargando…
Methylphenidate produces selective enhancement of declarative memory consolidation in healthy volunteers
RATIONALE: Methylphenidate inhibits the reuptake of dopamine and noradrenaline and is used to treat children with attention deficit hyperactivity disorder (ADHD). Besides reducing behavioral symptoms, it improves their cognitive function. There are also observations of methylphenidate-induced cognit...
Autores principales: | Linssen, A. M. W., Vuurman, E. F. P. M., Sambeth, A., Riedel, W. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360847/ https://www.ncbi.nlm.nih.gov/pubmed/22169884 http://dx.doi.org/10.1007/s00213-011-2605-9 |
Ejemplares similares
-
Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate
por: Linssen, Anke M. W., et al.
Publicado: (2011) -
Methylphenidate significantly improves declarative memory functioning of adults with ADHD
por: Verster, Joris C., et al.
Publicado: (2010) -
The effects of the soluble guanylate cyclase stimulator riociguat on memory performance in healthy volunteers with a biperiden-induced memory impairment
por: Borghans, Laura G. J. M., et al.
Publicado: (2018) -
Declarative and Non-declarative Memory Consolidation in Children with Sleep Disorder
por: Csábi, Eszter, et al.
Publicado: (2016) -
Methylphenidate during early consolidation affects long-term associative memory retrieval depending on baseline catecholamines
por: Wagner, Isabella C., et al.
Publicado: (2016)